Cargando…

Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells

BACKGROUND: Prostate cancer stem-like cells (PCSCs) likely participate in tumor progression and recurrence and demonstrate resistance to chemotherapy. The Notch pathway plays a role in the maintenance of the stemness in PCSCs. This study aimed to investigate the efficacy of Notch signaling inhibitio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lei, Zi, Hao, Luo, Yi, Liu, Tongzu, Zheng, Hang, Xie, Conghua, Wang, Xinghuan, Huang, Xing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318403/ https://www.ncbi.nlm.nih.gov/pubmed/32586404 http://dx.doi.org/10.1186/s13287-020-01773-w

Ejemplares similares

Flexible ureteroscopy training for surgeons using isolated porcine kidneys in vitro
por: Hu, Dongliang, et al.
Publicado: (2015)

Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and Chemoradiotherapy
por: Wang, Lei, et al.
Publicado: (2013)

Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer
por: Mimeault, Murielle, et al.
Publicado: (2015)

The inhibitory effect of melatonin on human prostate cancer
por: Shen, Dexin, et al.
Publicado: (2021)

HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro
por: Du, Zhongbo, et al.
Publicado: (2018)

Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer
por: Niu, Xiao-Bing, et al.
Publicado: (2017)

HOTAIR expands the population of prostatic cancer stem-like cells and causes Docetaxel resistance via activating STAT3 signaling
por: Wang, Ning, et al.
Publicado: (2020)

Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells
por: Wang, Quan, et al.
Publicado: (2018)

Inhibition of Janus Kinase 1 synergizes docetaxel sensitivity in prostate cancer cells
por: Nalairndran, Geetha, et al.
Publicado: (2021)

Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2022)

Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway
por: Cao, Rui, et al.
Publicado: (2016)

β‐Elemene Selectively Inhibits the Proliferation of Glioma Stem‐Like Cells Through the Downregulation of Notch1
por: Feng, Hai‐bin, et al.
Publicado: (2016)

The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review
por: Chen, Long, et al.
Publicado: (2014)

Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells
por: Vakhrusheva, Olesya, et al.
Publicado: (2022)

Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia
por: Wang, Xiaolong, et al.
Publicado: (2023)

DNA Methylation-Based Panel Predicts Survival of Patients With Clear Cell Renal Cell Carcinoma and Its Correlations With Genomic Metrics and Tumor Immune Cell Infiltration
por: Liu, Xiao-Ping, et al.
Publicado: (2020)

Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel
por: Wang, Huming, et al.
Publicado: (2023)

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
por: Mohr, Lisa, et al.
Publicado: (2017)

Corrigendum: Inhibition of O-GlcNAc transferase sensitizes prostate cancer cells to docetaxel
por: Xia, Mingyue, et al.
Publicado: (2023)

Undifferentiated prostate cancer treated with docetaxel
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer
por: Ku, ShengYu, et al.
Publicado: (2014)

Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells
por: Lin, Changyi, et al.
Publicado: (2020)

Generation of anti-Notch antibodies and their application in blocking Notch signalling in neural stem cells
por: Falk, Ronny, et al.
Publicado: (2012)

PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy
por: Zeng, Jin, et al.
Publicado: (2018)

Wogonin induces retinal neuron-like differentiation of bone marrow stem cells by inhibiting Notch-1 signaling
por: Shu, Qinmeng, et al.
Publicado: (2017)

The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells
por: Gruber, Martina, et al.
Publicado: (2019)

Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance
por: Martinez, Shannalee R., et al.
Publicado: (2023)

Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling
por: Ge, Jianchao, et al.
Publicado: (2022)

Treatment outcomes with radium-223 in docetaxel-naïve versus docetaxel-treated metastatic castration-resistant prostate cancer patients: Real-world evidence from Taiwan
por: Chiang, Ping-Chia, et al.
Publicado: (2023)

Molecular mechanisms of docetaxel resistance in prostate cancer
por: Sekino, Yohei, et al.
Publicado: (2020)

Radiosensitization of Clioquinol Combined with Zinc in the Nasopharyngeal Cancer Stem-like Cells by Inhibiting Autophagy in Vitro and in Vivo
por: Ke, Yuan, et al.
Publicado: (2020)

Bevacizumab and Weekly Docetaxel in Patients with Metastatic Castrate-Resistant Prostate Cancer Previously Exposed to Docetaxel
por: Francini, Filippo, et al.
Publicado: (2011)

Computer-aided analysis of quercetin mechanism of overcoming docetaxel resistance in docetaxel-resistant prostate cancer
por: Omoboyede, Victor, et al.
Publicado: (2023)

GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
por: Karanika, Styliani, et al.
Publicado: (2015)

E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases
por: Zhao, Peng, et al.
Publicado: (2010)

Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer
por: Lin, Jianzhong, et al.
Publicado: (2013)

Increased Notch signaling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells
por: Kwon, Oh-Joon, et al.
Publicado: (2014)

Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer
por: Shen, Yongmei, et al.
Publicado: (2019)

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer
por: Zhuang, Eric, et al.
Publicado: (2021)

Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer
por: Huang, Houbao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qeqj6t88ggdm6tvm7aa08hh3f